EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mechanism of inert inflammation in an immune checkpoint blockade-resistant tumor subtype bearing transcription elongation defects

Vishnu Modur, Belal Muhammad, Jun-Qi Yang, Yi Zheng, Kakajan Komurov, Fukun Guo

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.112364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Vishnu Modur und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati Co…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical response to immune checkpoint blockade (ICB) correlates with tumor-infiltrating cytolytic T lymphocytes (CTLs) prior to treatment. However, many of these inflamed tumors resist ICB through unknown mechanisms. We show that tumors with transcription elongation deficiencies (TEdef+), which we previously reported as being resistant to ICB in mouse models and the clinic, have high baseline CTLs. We show that high baseline CTLs in TEdef+ tumors result from aberrant activation of the nucleic acid sensing-TBK1-CCL5/CXCL9 signaling cascade, which results in an immunosuppressive microenvironment with elevated regulatory T cells and exhausted CTLs. ICB therapy of TEdef+ tumors fail to increase CTL infiltration and suppress tumor growth in both experimental and clinical settings, suggesting that TEdef+, along with surrogate markers of tumor immunogenicity such as tumor mutational burden and CTLs, should be considered in the decision process for patient immunotherapy indication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsNeoplasmsAnimalsMiceHumansImmunotherapySignal TransductionInflammationTumor Microenvironment

Stichwörter der Autor:innen

CCL5CP: CancerCTLICBTBK1TILTregchemokinedsRNAimmune exhaustiontranscription elongation defects (TE(def))

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Division of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address: vishnu.mod…
  • Division of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Division of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address: yi.zheng@c…
  • Champions Oncology, Inc, Hackensack, NJ, USA. Electronic address: komurov@hotmail.com.
  • Division of Experimental Hematology and Cancer Biology, Children's Hospital Medical Center, and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address: fukun.guo@…

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Modur, V., Muhammad, B., Yang, J. Q., Zheng, Y., Komurov, K., & Guo, F. (2023). Mechanism of inert inflammation in an immune checkpoint blockade-resistant tumor subtype bearing transcription elongation defects. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112364

Vancouver

Modur V, Muhammad B, Yang JQ, Zheng Y, Komurov K, Guo F. Mechanism of inert inflammation in an immune checkpoint blockade-resistant tumor subtype bearing transcription elongation defects. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112364

BibTeX
@article{Modur2023,
  author = {Modur, Vishnu and Muhammad, Belal and Yang, Jun-Qi and Zheng, Yi and Komurov, Kakajan and Guo, Fukun},
  title = {Mechanism of inert inflammation in an immune checkpoint blockade-resistant tumor subtype bearing transcription elongation defects},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.112364}
}
Kostenlos starten →